Article
Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1).
British journal of pharmacology - 1 Jan 2015
Knapman Alisa, Connor Mark
Abstract excerpt
UNLABELLED: There is significant variability in individual responses to opioid drugs, which is likely to have a significant genetic component. A number of non-synonymous single-nucleotide polymorphisms (SNPs) in the coding regions of the μ-opioid receptor gene (OPRM1) have been postulated to contribute to this variability. Although many studies have investigated the clinical influences of these μ-opioid receptor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
